Molecular Imaging, Inc. and Oncotest GmbH Bring the Power of in vivo Imaging to Patient Derived Tumor Xenografts

Molecular Imaging, Inc. (“Molecular Imaging”) and Oncotest GmbH (“Oncotest”) announced today that they have entered into a collaboration and co-promotion agreement to apply  Molecular Imaging’s experience and expertise in in-vivo pre-clinical Imaging to the pioneering Patient Derived Xenograft (PDX) work of Oncotest. Under the terms of the agreement both companies will promote the ability to […]

Molecular Imaging, Inc initiates search for Director, Oncology pharmaco-IMAGING

Molecular Imaging, Inc., (MII) a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, today announced it has initiated a global search to fill a newly created role: Director, Oncology pharmaco-IMAGING. The new position is aimed at building on an existing successful business to intensify focus on oncology […]

Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging

The free webinar, which will take place on September 10, 2013 at 11am ET, will feature presentations by Patrick McConville, Chief Scientific Officer of Molecular Imaging, and Maria Vosjan of BV Cyclotron VU. Dr. McConville will review the dual labeling and imaging strategy and related challenges. He will provide an overview of the key imaging […]

Molecular Imaging, Inc. hires Scott Wise as Director, Study Operations and Sr. Research Advisor, Molecular Targets.

Molecular Imaging, Inc., a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, today announced that Scott C. Wise, M.S has joined the company as the new  Director, Study Operations and Sr. Research Advisor, Molecular Targets. Mr. Wise was formerly Senior Director of Biology at Deciphera Pharmaceuticals. He […]

Molecular Imaging, Inc. Adds SPECT Capabilities to Its Broad Suite of in vivo Imaging Tools

Molecular Imaging, Inc, a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, today announced that it now offers SPECT imaging as part of its suite of imaging modalities. Molecular Imaging, Inc has expanded its preclinical nuclear medicine program with the addition of Single Photon Emission Computed Tomography […]

Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging

Molecular Imaging, Inc. (Molecular Imaging), a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, today announced that it has entered into a licensing agreement with Dana-Farber Cancer Institute to access a substantial number of luciferase-enabled cancer cell lines developed at Dana-Farber. Access to these unique lines dramatically […]

Molecular Imaging, Inc. Featured in May 15th Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News delves into the changes in CROs to meet the evolving needs of their clients in the May 15th article, “CRO Capabilities Expand to Suit Client Needs”. The growing reliance on imaging prompted a discussion with Patrick McConville, Ph.D., co-founder and CSO, Molecular Imaging (MI). According to Dr. McConville, MII uses […]

Molecular Imaging Closes Series A Financing Round Over-Subscribed at $9.9 million

Ann Arbor-based Molecular Imaging, Inc. announced today that it has closed its Series A financing round, originally targeted for $8.5 million, at $9.9 million. The company is pleased to announce that it has secured a $2.5 million investment from Beringea through the $185 million InvestMichigan! Growth Capital Fund plus another $350,000 from existing shareholders Baird […]